Publisher
Springer Science and Business Media LLC
Reference47 articles.
1. Compston, A. & Coles, A. Multiple sclerosis. Lancet 372, 1502–1517, doi:
10.1016/S0140-6736(08)61620-7
(2008).
2. Rosati, G. The prevalence of multiple sclerosis in the world: an update. Neurol Sci 22, 117–139, doi:
10.1007/s100720170011
(2001).
3. Tullman, M. J. Overview of the epidemiology, diagnosis, and disease progression associated with multiple sclerosis. Am J Manag Care 19, S15–20 (2013).
4. Hauser, S. L. & Oksenberg, J. R. The neurobiology of multiple sclerosis: genes, inflammation, and neurodegeneration. Neuron 52, 61–76, doi:
10.1016/j.neuron.2006.09.011
(2006).
5. Owens, G. M., Olvey, E. L., Skrepnek, G. H. & Pill, M. W. Perspectives for managed care organizations on the burden of multiple sclerosis and the cost-benefits of disease-modifying therapies. J Manage Care Pharm 19, S41–S53, doi:
10.18553/jmcp.2013.19.s1.S41
(2013).
Cited by
20 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献